SE409454B - Analogiforfarande for framstellning av 3-halogen 4-etiksyra pyrazolderivat - Google Patents

Analogiforfarande for framstellning av 3-halogen 4-etiksyra pyrazolderivat

Info

Publication number
SE409454B
SE409454B SE7410419A SE7410419A SE409454B SE 409454 B SE409454 B SE 409454B SE 7410419 A SE7410419 A SE 7410419A SE 7410419 A SE7410419 A SE 7410419A SE 409454 B SE409454 B SE 409454B
Authority
SE
Sweden
Prior art keywords
halogenic
preparation
pyrazole derivatives
acid pyrazole
analogical procedure
Prior art date
Application number
SE7410419A
Other languages
English (en)
Other versions
SE7410419L (sv
Inventor
G Rainer
R Riedel
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of SE7410419L publication Critical patent/SE7410419L/xx
Publication of SE409454B publication Critical patent/SE409454B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7410419A 1973-08-16 1974-08-15 Analogiforfarande for framstellning av 3-halogen 4-etiksyra pyrazolderivat SE409454B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU68238A LU68238A1 (sv) 1973-08-16 1973-08-16

Publications (2)

Publication Number Publication Date
SE7410419L SE7410419L (sv) 1975-02-17
SE409454B true SE409454B (sv) 1979-08-20

Family

ID=19727442

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7410419A SE409454B (sv) 1973-08-16 1974-08-15 Analogiforfarande for framstellning av 3-halogen 4-etiksyra pyrazolderivat

Country Status (18)

Country Link
JP (1) JPS5230515B2 (sv)
AT (1) AT339892B (sv)
BE (1) BE818912A (sv)
CA (1) CA1048499A (sv)
CH (1) CH601250A5 (sv)
DE (2) DE2438779C3 (sv)
DK (1) DK136953B (sv)
ES (1) ES429247A1 (sv)
FI (1) FI57584C (sv)
FR (1) FR2240732B1 (sv)
GB (1) GB1475806A (sv)
IE (1) IE39999B1 (sv)
LU (1) LU68238A1 (sv)
NL (1) NL169070C (sv)
NO (1) NO140733C (sv)
SE (1) SE409454B (sv)
YU (1) YU222474A (sv)
ZA (1) ZA745252B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5297383A (en) * 1976-02-13 1977-08-16 Ngk Spark Plug Co Ceramic honeycomb structures for exhaust gas purification
HUP0304101A3 (en) * 2003-12-22 2008-10-28 Sanofi Aventis Pyrazole derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates

Also Published As

Publication number Publication date
IE39999L (en) 1975-02-16
IE39999B1 (en) 1979-02-14
FR2240732A1 (sv) 1975-03-14
YU222474A (en) 1983-04-27
DK136953C (sv) 1978-05-29
FI57584C (fi) 1980-09-10
NO742941L (sv) 1975-03-17
DE2462459A1 (de) 1977-04-07
CH601250A5 (sv) 1978-06-30
NL169070B (nl) 1982-01-04
DK438174A (sv) 1975-04-28
FR2240732B1 (sv) 1978-07-21
DE2438779C3 (de) 1979-09-20
GB1475806A (en) 1977-06-10
JPS5049278A (sv) 1975-05-01
FI242274A (sv) 1975-02-17
LU68238A1 (sv) 1975-05-21
NL7410921A (nl) 1975-02-18
FI57584B (fi) 1980-05-30
NO140733C (no) 1979-10-31
SE7410419L (sv) 1975-02-17
ATA671174A (de) 1977-03-15
NO140733B (no) 1979-07-23
AT339892B (de) 1977-11-10
DE2438779A1 (de) 1975-02-27
ES429247A1 (es) 1976-08-16
CA1048499A (en) 1979-02-13
ZA745252B (en) 1976-03-31
DE2462459C3 (de) 1979-10-04
BE818912A (fr) 1975-02-17
DK136953B (da) 1977-12-19
DE2462459B2 (de) 1979-02-08
DE2438779B2 (de) 1979-01-25
NL169070C (nl) 1982-06-01
JPS5230515B2 (sv) 1977-08-09

Similar Documents

Publication Publication Date Title
SE423631B (sv) Forfarande for framstellning av oxaalhyl-dialkylxantiner
SE414304B (sv) Estrar av cyklopropankarboxylsyraderivat for pesticidiskt bruk
SE7710599L (sv) Forfarande for framstellning av bensisoxazoler
SE7908625L (sv) Acetylglykosylmykofenolsyraforeningar for framstellning av glykosylmykofenolsyraforeningar
SE420604B (sv) Forfarande for framstellning av oxazolderivat
SE411212B (sv) Forfarande for framstellning av 3-halogen-cefalosporiner
NO138530C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-substituerte pyrazolon-(5)-derivater
SE7712151L (sv) Forfarande for framstellning av linkomycinderivat
NO146596C (no) Fremgangsmaate for fremstilling av 6-deoksytetracykliner
SE417601B (sv) Forfarande for framstellning av amidinokarbamider
NO790627L (no) Fremgangsmaate for fremstilling av hydroksyalkylxantiner
SE413404B (sv) Forfarande for framstellning av pyrazolderivat
NO843825L (no) Fremgangsmaate for fremstilling av 6-deoksytetracyklin
SE409716B (sv) Analogiforfarande for framstellning av 11beta-alkyl-deltaŸ4-estrener
NO139439C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolon-(5)-forbindelser
NO138561C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme cykloalkylfenoksykarboksylsyrederivater
SE416648B (sv) Forfarande for framstellning av pyrazoler
SE421693B (sv) Forfarande for framstellning av n-substituerade 1-amino-3-fenoxi-propanoler-(2)
NO138250C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzylaminer
SE7613500L (sv) Forfarande for framstellning av cefemderivat
NO139125C (no) Analogifremgangsmaate for fremstilling av cykloheksantetrolderivater
SE402111B (sv) Analogiforfarande for framstellning av pregnansyraderivat
SE411211B (sv) Forfarande for framstellning av 3-halogencefalosporiner
SE409994B (sv) Forfarande for framstellning av amidinokarbamider
DK136249B (da) Analogifremgangsmade til fremstilling af xanthenderivater